-
Mashup Score: 0IMVARIA Receives 510(k) Clearance for ScreenDx, a First-of-its-Kind Screening Algorithm to Assess for Interstitial Lung Disease - 5 day(s) ago
IMVARIA Inc., a health tech company pioneering AI-driven digital biomarker solutions, today announced its second FDA authorization, securing 510(k) cl
Source: www.businesswire.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 65BlossomHill Therapeutics Appoints Geoff Oxnard, M.D., as Chief Medical Officer and Executive Vice President - 10 day(s) ago
BlossomHill Therapeutics, Inc., a clinical-stage biotechnology company focused on the design and development of small molecule medicines for treating
Source: www.businesswire.comCategories: General Medicine News, Hem/OncsTweet-
Excited to announce I'm joining BlossomHill Therapeutics as CMO! I’ve always believed in patient-centered cancer therapies. None better to team with than our CEO Jean Cui who designed some of the most effective & creative macrocyclic TKIs on the market: https://t.co/723zQ2s6ob
-
-
Mashup Score: 9PetPace Health 2.0 Smart Collar Named “IoT Wearable Device of the Year” in 9th Annual IoT Breakthrough Awards Program - 11 day(s) ago
PetPace™, the leading provider of the most advanced and innovative pet wearable technology in the world, powered by artificial intelligence and machin
Source: www.businesswire.comCategories: General Medicine News, General HCPsTweet-
PetPace Health 2.0 Smart Collar Named “IoT Wearable Device of the Year” in 9th Annual IoT Breakthrough Awards Program - https://t.co/EHcjbSFgUf
-
-
Mashup Score: 6
Pfizer Inc. (NYSE: PFE) today announced positive topline results from its pivotal Phase 3 CREST trial evaluating sasanlimab, an investigational anti-P
Source: www.businesswire.comCategories: General Medicine News, Hem/OncsTweet-
@tompowles1 Fantastic News for patients !! https://t.co/WW5bnKAXCf
-
-
Mashup Score: 1
Alleviant Medical, Inc., a privately held medical device company pioneering a no-implant atrial shunt for heart failure, today announced two significa
Source: www.businesswire.comCategories: General Medicine News, CardiologistsTweet-
Novel Heart Failure Technology from Alleviant Medical Gains FDA Approval for New Pivotal Trial and Breakthrough Designation for Significant Patient Population - https://t.co/AMGxhlYYYZ
-
-
Mashup Score: 9CES 2025: SoundHound AI Debuts Its First Ever In-Vehicle Voice Assistant With On-The-Go Food Ordering - 14 day(s) ago
SoundHound AI, Inc. (Nasdaq: SOUN), a global leader in voice artificial intelligence, today unveiled the first ever in-vehicle voice commerce platform
Source: www.businesswire.comCategories: General Medicine News, General HCPsTweet-
#ces2025 : @SoundHound AI Debuts Its First Ever In-Vehicle Voice Assistant With On-The-Go Food Ordering https://t.co/Dwb2zZCl5y
-
-
Mashup Score: 2Highlander Health Announces Inaugural Investment of Target RWE - 15 day(s) ago
Highlander Health today announced the acquisition of Target RWE from existing investors, including 22C Capital.
Source: www.businesswire.comCategories: General Medicine News, General HCPsTweet-
First acquisition by @dramyabernethy's Highlander Health-a longitudinal RWD co called @TargetRWE: https://t.co/Yez1et5r2o The value of high quality *longitudinal* health data=theme I've been hearing about a lot recently. Excited & curious to see what Amy is building towards...
-
-
Mashup Score: 5U.S. FDA Approves Pfizer’s BRAFTOVI® Combination Regimen as First-Line Treatment of BRAF V600E-Mutant Metastatic Colorectal Cancer - 1 month(s) ago
Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved BRAFTOVI® (encorafenib) in combination with cetu
Source: www.businesswire.comCategories: General Medicine News, Hem/OncsTweet-
U.S. FDA Approves Pfizer’s BRAFTOVI® Combination Regimen as First-Line Treatment of BRAF V600E-Mutant Metastatic Colorectal Cancer https://t.co/b7EICqCEIH
-
-
Mashup Score: 9
Pfizer Inc. (NYSE:PFE) and Alliance Foundation Trials, LLC (AFT) today announced results from the Phase 3 PATINA trial demonstrating that the addition
Source: www.businesswire.comCategories: General Medicine News, Hem/OncsTweet-
Major practice change data out now. Combination of palbociclib, anti-HER2 therapy, and endocrine therapy. For HR* HER2+ MBC. https://t.co/l9nXtBsMOd #SABCS24
-
-
Mashup Score: 0
Meet Fello: The innovative peer support platform for the loneliness epidemic which connects anyone seeking connection and guidance to people who can h
Source: www.businesswire.comCategories: General Medicine News, General HCPsTweet-
Fello, the Peer Support Platform for the $Loneliness Epidemic, Raises $10.4M https://t.co/i6jrRxCA4n
-
.@IMVARIAinc Receives 510(k) Clearance for ScreenDx, a First-of-its-Kind #Screening Algorithm to Assess for Interstitial Lung Disease | #ILD #radiology #AI https://t.co/v67gOTkUIv